Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System

Anticancer Research - Greece
doi 10.21873/anticanres.12037
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

International Institute of Anticancer Research

Related search

ALK in Neuroblastoma: Biological and Therapeutic Implications

Cancers
Cancer ResearchOncology
2018English

Neurokinin 1 Receptor Expression in the Rat Retina

Journal of Comparative Neurology
Neuroscience
1997English

Therapeutic Targeting of Non-Oncogene Dependencies in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Therapeutic Targeting of the Complement System

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

Substance P (Neurokinin-1) and Neurokinin a (Neurokinin-2) Receptor Gene and Protein Expression in the Healthy and Inflamed Human Intestine

American Journal of Pathology
Forensic MedicinePathology
2000English

Molecular Pathways: Targeting Resistance in the Androgen Receptor for Therapeutic Benefit

Clinical Cancer Research
Cancer ResearchOncology
2013English

Evolving Role of Neurokinin 1-Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting

OncoTargets and Therapy
OncologyPharmacology
2018English

Intrathecal Neurokinin-1 Receptor Antagonist Reduces Isoflurane MAC in Rats

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1997English

Exposing HIV-1 Env: Implications for Therapeutic Strategies

Clinical and Investigative Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy